✦ LIBER ✦

Stem cell plasticity: Learning from hepatogenic differentiation strategies

✍ Scribed by Agnieszka Banas; Yusuke Yamamoto; Takumi Teratani; Takahiro Ochiya

Book ID: 118283276
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 481 KB
Volume: 236
Category: Article
ISSN: 1058-8388
DOI: 10.1002/dvdy.21330

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

861 CHIMERIC PHENOTYPE OF MOUSE MESENCHY

861 CHIMERIC PHENOTYPE OF MOUSE MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE AFTER HEPATOGENIC DIFFERENTIATION

✍ L. Bachmetov; H. Gitman; R. Zemel; R. Tur-Kaspa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Evaluation of hepatogenic differentiatio

Evaluation of hepatogenic differentiation potential of menstrual blood derived stem cells

✍ Sayeh Khanjani; Hale Edalatkhah; Saeed Talebi; Amirhasan Zarnani; Manijeh Khanmo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Metabolic Plasticity in Stem Cell Homeos

Metabolic Plasticity in Stem Cell Homeostasis and Differentiation

✍ Folmes, Clifford D.L.; Dzeja, Petras P.; Nelson, Timothy J.; Terzic, Andre 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 946 KB

Stem cell plasticity, osteogenic differe

Stem cell plasticity, osteogenic differentiation and the third dimension

✍ Markus Rottmar; Maria Håkanson; Michael Smith; Katharina Maniura-Weber 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 506 KB

Mesenchymal stem cells: plasticity of di

Mesenchymal stem cells: plasticity of differentiation

✍ Nicholas A. Wright; William R. Otto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Differentiated human adipose-derived ste

Differentiated human adipose-derived stem cells exhibit hepatogenic capability in vitro and in vivo

✍ Joseph C. Ruiz; John W. Ludlow; Sonya Sherwood; Gang Yu; Xiying Wu; Jeffrey M. G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 1 views

## Abstract The availability of suitable human livers for transplantation falls short of the number of potential patients. In addition, the availability of primary human hepatocytes for cell‐therapy and drug development applications is significantly limited; less than 700 livers per year are availa